Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for AVTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 140.60M
March 31, 2026 25.20M
December 31, 2025 117.20M
September 30, 2025 171.70M
June 30, 2025 124.80M
March 31, 2025 81.30M
December 31, 2024 145.80M
September 30, 2024 204.00M
June 30, 2024 235.30M
March 31, 2024 106.90M
December 31, 2023 201.00M
September 30, 2023 193.00M
June 30, 2023 138.10M
March 31, 2023 191.50M
December 31, 2022 172.00M
September 30, 2022 219.30M
June 30, 2022 191.20M
Date Value
March 31, 2022 127.70M
December 31, 2021 261.00M
September 30, 2021 229.30M
June 30, 2021 240.40M
March 31, 2021 111.80M
December 31, 2020 285.80M
September 30, 2020 266.20M
June 30, 2020 75.70M
March 31, 2020 240.50M
December 31, 2019 74.90M
September 30, 2019 184.80M
June 30, 2019 -19.90M
March 31, 2019 62.60M
December 31, 2018
September 30, 2018
June 30, 2018 -34.60M
March 31, 2018 33.90M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 138.10M
Champions Oncology, Inc. -2.237M
Personalis, Inc. -29.55M
Adaptive Biotechnologies Corp. -7.584M
10X Genomics, Inc. 15.39M